These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 359486)

  • 1. A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels.
    Shani A; Ritts RE; Thynne GS; Weiland LH; Silvers A; Moertel CG; Go VL
    Int J Cancer; 1978 Aug; 22(2):113-9. PubMed ID: 359486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of tube leukocyte adherence inhibition assay and standard physical methods for diagnosing colorectal cancer.
    Ayeni AO; Thomson DM; MacFarlane JK; Daly D
    Cancer; 1981 Oct; 48(8):1855-62. PubMed ID: 7026024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucocyte adherence inhibition and carcinoembryonic antigen in combination for diagnosis of colorectal cancer.
    Payne JE; Dent O; Chapuis PH; Meyer HJ; Sutherland MA; Ruwoldt A
    J Surg Oncol; 1983 Mar; 22(3):212-5. PubMed ID: 6339824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
    Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
    Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
    Tataryn DN; MacFarlane JK; Murray D; Thomson DM
    Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
    Mounielou PM; Clemente F; Estival A; Ribet A
    Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
    Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
    Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukocyte adherence inhibition test and carcinoembryonic antigen in colorectal carcinoma].
    Shani A; Weissman Z; Cohen Z; Amruch D; Cohen O; Nissim F; Shindel A; Sela A; Rosen A; Modan M; Bentwich Z
    Harefuah; 1981 Nov; 101(10):241-3. PubMed ID: 6749609
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukocyte adherence inhibition assay in immunodiagnosis of colon cancers.
    Cavallini G; Berti G; Tioli P
    Ital J Surg Sci; 1984; 14(4):281-8. PubMed ID: 6398321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
    Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
    Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
    Wagner T; Peschel U; Heydrich D; Ritter U
    Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.
    Wanebo HJ; Rao B; Pinsky CM; Hoffman RG; Stearns M; Schwartz MK; Oettgen HF
    N Engl J Med; 1978 Aug; 299(9):448-51. PubMed ID: 683276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of leucocyte adherence inhibition microassay using colorectal cancer cell lines.
    Machida S; Yamauchi M; Sato M; Ishioka T; Takashima K; Nishikawa T; Fukushima M; Koie H
    Gan; 1980 Jun; 71(3):387-92. PubMed ID: 6998824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients.
    Kitsukawa Y
    Jpn J Surg; 1979 Jun; 9(2):102-9. PubMed ID: 449127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of carcinoembryonic antigen measurement in feces of patients with colorectal cancer.
    Shimano T; Okuda H; Monden T; Inaji H; Mori T
    Dis Colon Rectum; 1987 Aug; 30(8):607-10. PubMed ID: 3622164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
    MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
    Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of leukocyte adherence inhibition assay to patients with colorectal cancer. Comparison with serum level of carcinoembryonic antigen and sialic acid.
    Liu HP; Yan ZS; Zhang SS
    Dis Colon Rectum; 1989 Mar; 32(3):210-3. PubMed ID: 2646084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
    Halliday WJ; Maluish AE; Stephenson PM; Davis NC
    Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.
    Goslin R; Steele G; Macintyre J; Mayer R; Sugarbaker P; Cleghorn K; Wilson R; Zamcheck N
    Ann Surg; 1980 Dec; 192(6):747-51. PubMed ID: 7447529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.